The bioequivalence study of Folifer-Z®: A new formulation of sustained-release iron and zinc

International Journal of Pharmaceutics

Volumn 178, Issue 2, 1999, Pages 171-181

  Salhab, Abdulazim S ^a   Zmeili, Suheil M ^a   Gharaibeh, Munir N ^a   Elayan, Hamzeh H ^a   Sallam, Elsayyed ^b   Al Deleq, Suleiman ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b Research and Development Division   (Jordan)

Author keywords

Bioequivalence; Iron; Pharmacokinetics; Zinc

Indexed keywords

FEFOL Z; FERROUS SULFATE; FOLIC ACID; FOLIFER Z; IRON; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUSTAINED RELEASE FORMULATION;

ADULT; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; HUMANS; IRON; MALE; TABLETS; THERAPEUTIC EQUIVALENCY; ZINC;

EID: 0032994462     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00368-8     Document Type: Article

References (28)

1. Artiss J.D., Vinogradov S., Zak B. Spectropotometric study of several sensitive reagents for serum iron. Clin. Biochem. 14:1981;311-315.
2. Chlou W.L., Kayser S.R., Orr J.M., Stella V.J. Ferrous sulfate. J. Am. Pharmaceut. Assoc. 17:1997;337-380.
3. Cook J.D., Lipschitz D.A., Skikne B.S. Absorption of controlled-release iron. Clin. Pharmacol. Ther. 32:1982;531-539.
4. Couturier E., Van-Onderbergen A., Bosson D., Neve J. Circadian variations in plasma zinc and cortisol in man. J. Trace Elem. Electrolytes Health Dis. 2:1988;245-249.
5. Davies S., Stewart A. Nutritional Medicine. 1987;Avon Press, New York.
6. Dietzfelbinger H. Bioavailability of bi- and trivalent oral iron preparations, investigations of iron absorption by postabsorption serum iron concentrations curves. Arzneim.-Forsch. Drug Res. 37:1987;107-112.
7. Dursun N., Aydogan S. The influence of dietary iron on zinc in rat. Biol. Trace Elem. Res. 48:1995;161-171.
8. Ekenved G., Norrby A., Solvell L. Serum iron increase as a measure of iron absorption-studies on the correlation with total absorption. Scand. J. Haematol. Suppl. 8:1972;31-49.
9. Eskelinen S., Haikonen M., Raisanen S. Ferene S as the chromogen for serum iron determinations. Scand. J. Clin. Lab. Invest. 43:1983;453-455.
10. Fabris N. Biomarkers of aging in the neuroendocrine-immune do main. Time for a new theory of aging? Ann. New York Acad. Sci. USA. 663:1992;335-348.
11. Fabris N., Moccchegiani E., Muzzioli M., Proviciali M. Role of zinc in neuroendocrine-immune interactions during aging. Ann. New York Acad. Sci. USA. 621:1991;314-326.
12. Finch C.A., Cook J.D., Labbe R.F., Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood. 50:1977;441-447.
13. Flanagan P.R., Haist J., Valberg J.D., Valberg L.S. Comparative effects of iron deficiency induced by bleeding and a low-iron diet on the intestinal absorptive interactions of iron, cobalt, manganese, zinc, lead and cadmium. J. Nutr. 110:1980;1754-1763.
14. Gordeuk V.R., Brittenham G.M., Mclaren C.E., Hughus M.A., Keating L.J. Carbonyl iron therapy for iron deficiency anemia. Blood. 67:1986;745-752.
15. Gordon P.R., Woodruf C.W., Anderson H.L., O'Dell B.L. Effect of acute zinc depriviation on plasma zinc and platelet aggregation in adult males. Am. J. Clin. Nutr. 35:1982;113-119.
16. Hauschke D., Steinijans V.W., Diletti E.A. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 28:1990;72-78.
17. Hoadley J.E., Leinart A.S., Cousins R.J. Kinetic analysis of zinc uptake and serosal transfer by vascular perfused rat intestine. Am. J. Physiol. 252:1985;G825-G831.
18. Levy F., Andersen P., Ekren T. Absorption and side-effects after peroral administreation of sustained release iron tablets. Acta. Med. Scand. 204:1978;303-310.
19. Milman N., Sondergaard M. Iron stores in male blood donors evaluated by serum ferritin. Transfusion. 24:1984;464-468.
20. Nielsen J.B., Ikala E., Solvell L., Rasmussen E.B., Ekenved G. Absorption of iron from slow-release and rapidly disintegrating tablets. A comparative study in normal subjects, blood donors and subjects with iron deficiency anemia. Scand. J. Hematol. 28:1976;89-97.
21. Sandsteal H.H. Understanding zinc: recent observations and interpretations. J. Lab. Clin. Med. 124:1994;322-327.
22. Simon T.L., Garry P.J., Hooper E.M. Iron stores in blood donors. J. Am. Med. Assoc. 245:1981;2038-2043.
23. Simon T.L., Hunt W.C., Garry P.J. Iron supplementation for menstruating female blood donors. Transfusion. 24:1984;469-472.
24. Solomons N. Competitive mineral-mineral interaction in the intestine. Implications for zinc absorption in humans. Inglett G.E. Nutritional Bioavailability of Zinc. 1983;247-271 American Chemical Society, Washington, DC.
25. Solomons N.W., Jacob R.A. Studies on the bioavailability of zinc in humans: effects of heme and nonheme iron on the absorption of zinc. Am. J. Clin. Nutr. 34:1981;475-482.
26. US Pharmacopeia XXIII, 1995. US Pharmacopeia Convetion, Rockville, MD, pp. 1929-1923.
27. Wallenburg H.C.S., Van Eijk H.G. Effect of oral iron supplementation during pregnancy on maternal and fetal iron status. J. Perinat. Med. 12:1984;7-12.
28. Tests for equivalence. Drug Information. 8:1994;77-84.